The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa

dc.contributor.authorNattrass, Nicoli
dc.contributor.authorGeffen, Nathan
dc.date.accessioned2016-05-22T18:06:16Z
dc.date.available2016-05-22T18:06:16Z
dc.date.issued2005
dc.date.updated2016-05-22T18:02:46Z
dc.description.abstractSouth Africa has started ‘rolling out’ highly active anti-retroviral therapy (HAART) through the public health sector, but implementation has been slow. Studies have shown that in Africa AIDS prevention may be more cost-effective than providing HAART; such published results provide some support for the South African government’s apparent reluctance to implement a large-scale rapid HAART roll-out. However, previous studies have not linked treatment and prevention plans, and do not, for the most part, consider the potential savings to the public health sector (e.g., fewer hospital admissions) that may arise from the introduction of HAART. The South African costing exercise summarised here avoids both these limitations. It provides an update of earlier work and takes into account the recent decline in antiretroviral drug prices. It shows that once HIV-related hospital costs are included in the calculation, the cost per HIV infection averted is lower in a treatment-plus-prevention intervention scenario than it is in a prevention-only scenario. This suggests that it is economically advantageous to fund a large-scale comprehensive intervention plan and that the constraints for doing so are political. Once human-rights considerations are included, the case for providing HAART is even more compelling.en_ZA
dc.identifier.apacitationNattrass, N., & Geffen, N. (2005). The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa. <i>African Journal of AIDS Research</i>, http://hdl.handle.net/11427/19761en_ZA
dc.identifier.chicagocitationNattrass, Nicoli, and Nathan Geffen "The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa." <i>African Journal of AIDS Research</i> (2005) http://hdl.handle.net/11427/19761en_ZA
dc.identifier.citationNattrass, N., & Geffen, N. (2005). The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa. African journal of AIDS research, 4(1), 65-67.en_ZA
dc.identifier.issn1608-5906en_ZA
dc.identifier.ris TY - Journal Article AU - Nattrass, Nicoli AU - Geffen, Nathan AB - South Africa has started ‘rolling out’ highly active anti-retroviral therapy (HAART) through the public health sector, but implementation has been slow. Studies have shown that in Africa AIDS prevention may be more cost-effective than providing HAART; such published results provide some support for the South African government’s apparent reluctance to implement a large-scale rapid HAART roll-out. However, previous studies have not linked treatment and prevention plans, and do not, for the most part, consider the potential savings to the public health sector (e.g., fewer hospital admissions) that may arise from the introduction of HAART. The South African costing exercise summarised here avoids both these limitations. It provides an update of earlier work and takes into account the recent decline in antiretroviral drug prices. It shows that once HIV-related hospital costs are included in the calculation, the cost per HIV infection averted is lower in a treatment-plus-prevention intervention scenario than it is in a prevention-only scenario. This suggests that it is economically advantageous to fund a large-scale comprehensive intervention plan and that the constraints for doing so are political. Once human-rights considerations are included, the case for providing HAART is even more compelling. DA - 2005 DB - OpenUCT DP - University of Cape Town J1 - African Journal of AIDS Research LK - https://open.uct.ac.za PB - University of Cape Town PY - 2005 SM - 1608-5906 T1 - The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa TI - The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa UR - http://hdl.handle.net/11427/19761 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/19761
dc.identifier.urihttp://www.tandfonline.com/doi/abs/10.2989/16085900509490343
dc.identifier.vancouvercitationNattrass N, Geffen N. The impact of reduced drug prices on the cost-effectiveness of HAART in South Africa. African Journal of AIDS Research. 2005; http://hdl.handle.net/11427/19761.en_ZA
dc.languageengen_ZA
dc.publisherNational Inquiry Services Centreen_ZA
dc.publisher.departmentCentre for Social Science Research(CSSR)en_ZA
dc.publisher.facultyFaculty of Humanitiesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.sourceAfrican Journal of AIDS Researchen_ZA
dc.source.urihttp://www.nisc.co.za/products/1/journals/african-journal-of-aids-research
dc.subject.otherantiretroviral therapy
dc.subject.otherHIV/AIDS
dc.subject.otherprevention
dc.subject.otherpublic health
dc.subject.othertreatment
dc.titleThe impact of reduced drug prices on the cost-effectiveness of HAART in South Africaen_ZA
dc.typeJournal Articleen_ZA
uct.type.filetypeText
uct.type.filetypeImage
uct.type.publicationResearchen_ZA
uct.type.resourceArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nattrass_impact_reduced_drug_2005.pdf
Size:
210.64 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections